MRSH
NYSEMARSH & MCLENNAN COMPANIES, INC.
Financials, Insurance Brokers
close 7 Aug 2026
52-week change
market cap
52-week range
Expected price
Expected price
$197.50 – $241.39
Current price
$191.65
Signal
Could be undervalued
A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.
Current multiples
Context
Forward — analyst consensus
Street view
5-year history
Dashed line: average of month-end values
P/E (TTM)
P/S (TTM)
P/B
FCF yield (TTM)
Dividend yield
period to 30 Jun 2026, filed 21 Jul 2026, close 7 Aug 2026
Discounted cash flow
Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.
Free cash flow, last ten years and TTM
5Y CAGR +10.51%10Y CAGR +12.33%
Assumptions
As filed — not assumptions
Result
Projected FCF, years 1–10
Hover for PV and growth
Projection detail
Override growth for any year; blank years use the uniform rate
| Year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | Terminal |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth, % | 2.5 | ||||||||||
| FCF | $5.27B | $5.82B | $6.43B | $7.11B | $7.86B | $8.68B | $9.60B | $10.60B | $11.72B | $12.95B | $241.34B |
| PV | $4.88B | $4.99B | $5.11B | $5.23B | $5.35B | $5.47B | $5.60B | $5.73B | $5.86B | $6.00B | $111.79B |
period to 30 Jun 2026, filed 21 Jul 2026, close 7 Aug 2026